sulfasalazine has been researched along with Precancerous Conditions in 5 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Precancerous Conditions: Pathological conditions that tend eventually to become malignant.
Excerpt | Relevance | Reference |
---|---|---|
" It has recently been suggested that presence of primary sclerosing cholangitis is another independent risk factor-especially for proximal colorectal dysplasia or cancer-and that treatment with sulfasalazine might reduce the frequency of colorectal cancer in ulcerative colitis; the present study was undertaken to shed light on the validity of these theories." | 3.71 | Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. ( Broomé, U; Lindberg, BU; Persson, B, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Shimizu, T | 1 |
Sohn, Y | 1 |
Choi, E | 1 |
Petersen, CP | 1 |
Prasad, N | 1 |
Goldenring, JR | 1 |
Wada, T | 1 |
Ishimoto, T | 1 |
Seishima, R | 1 |
Tsuchihashi, K | 1 |
Yoshikawa, M | 1 |
Oshima, H | 1 |
Oshima, M | 1 |
Masuko, T | 1 |
Wright, NA | 1 |
Furuhashi, S | 1 |
Hirashima, K | 1 |
Baba, H | 1 |
Kitagawa, Y | 1 |
Saya, H | 1 |
Nagano, O | 1 |
Rubin, DT | 1 |
LoSavio, A | 1 |
Yadron, N | 1 |
Huo, D | 1 |
Hanauer, SB | 1 |
Jess, T | 1 |
Loftus, EV | 1 |
Velayos, FS | 1 |
Winther, KV | 1 |
Tremaine, WJ | 1 |
Zinsmeister, AR | 1 |
Scott Harmsen, W | 1 |
Langholz, E | 1 |
Binder, V | 1 |
Munkholm, P | 1 |
Sandborn, WJ | 1 |
Lindberg, BU | 1 |
Broomé, U | 1 |
Persson, B | 1 |
5 other studies available for sulfasalazine and Precancerous Conditions
Article | Year |
---|---|
Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
Topics: Amino Acid Transport System y+; Animals; Atrophy; Cell Line; Cell Transdifferentiation; Chief Cells, | 2020 |
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
Topics: Adenocarcinoma; Amino Acid Transport System y+; Animals; Biomarkers, Tumor; Cell Transformation, Neo | 2013 |
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Case-Control Studies; Chemoprevention; Chronic Disease; Colitis, Ulcera | 2006 |
Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Topics: Adult; Case-Control Studies; Colonoscopy; Colorectal Neoplasms; Denmark; Female; Gastrointestinal Ag | 2007 |
Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cholangitis, Sclerosing; Co | 2001 |